表紙
市場調查報告書

表觀遺傳學的全球市場

Epigenetics

出版商 Global Industry Analysts, Inc. 商品編碼 912734
出版日期 內容資訊 英文 234 Pages
商品交期: 最快1-2個工作天內
價格
表觀遺傳學的全球市場 Epigenetics
出版日期: 2020年09月01日內容資訊: 英文 234 Pages
簡介

本報告提供全球表觀遺傳學市場調查,提供市場概要,各產品(試劑,套件,設備,酵素,服務),技術(DNA甲基化,組蛋白甲基化,組蛋白乙醯化,長鏈非編碼RNA,微型核糖核酸修飾,染色質結構),用途(腫瘤,腫瘤以外),各地區的市場佔有率,需求趨勢,銷售額的變化與預測,市場成長要素,競爭情形,主要企業的簡介等全面性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 競爭企業的市場佔有率
    • 競爭企業的市場佔有率:方案
  • 關注企業
  • 市場趨勢和成長要素
  • 全球市場預測

第3章 市場分析

  • 地區市場分析
  • 美國
    • 市場概要
    • 市場佔有率:各企業
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲各國
  • 亞太地區
  • 其他地區

第4章 競爭情形

  • ABCAM PLC
  • ACTIVE MOTIF
  • CELLCENTRIC
  • DIAGENODE SA
  • Eisai
  • F. HOFFMANN-LA ROCHE AG
  • ILLUMINA
  • MILLIPORESIGMA
  • NOVARTIS INTERNATIONAL AG
  • QIAGEN GMBH
  • THERMO FISHER SCIENTIFIC INC.
  • VALIRX PLC
  • ZYMO RESEARCH CORPORATION

第5章 調查資料

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-6259

Global Epigenetics Market to Reach $25.6 Billion by 2027

Amid the COVID-19 crisis, the global market for Epigenetics estimated at US$7.4 Billion in the year 2020, is projected to reach a revised size of US$25.6 Billion by 2027, growing at a CAGR of 19.5% over the analysis period 2020-2027. Reagents, one of the segments analyzed in the report, is projected to record a 19.9% CAGR and reach US$10.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Kits segment is readjusted to a revised 22.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.2 Billion, While China is Forecast to Grow at 18.8% CAGR

The Epigenetics market in the U.S. is estimated at US$2.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.4 Billion by the year 2027 trailing a CAGR of 18.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.3% and 16.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.4% CAGR.

Instruments Segment to Record 17.9% CAGR

In the global Instruments segment, USA, Canada, Japan, China and Europe will drive the 17.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$3.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.1 Billion by the year 2027.We bring years of research experience to this 16th edition of our report. The 234-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abcam PLC
  • Active Motif, Inc.
  • CellCentric
  • Diagenode SA
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • MilliporeSigma
  • Novartis International AG
  • Oncolys BioPharma Inc.
  • QIAGEN GmbH
  • Syndax Pharmaceuticals, Inc.
  • Thermo Fisher Scientific, Inc.
  • Valirx Plc
  • Zymo Research Corporation

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Product Overview
    • Epigenetics: A Prelude
    • US to Dominate the Epigenetics Market
    • Global Competitor Market Shares
    • Epigenetics Competitor Market Share Scenario Worldwide (in %): 2019 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prominence of Epigenetics Led Diagnostics
    • New Innovations and Techniques in Epigenetics
    • New Epigenetics Research Findings Creating Problems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Epigenetics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 2: Epigenetics Global Retrospective Market Scenario in US$ Million by Region/Country: 2012
    • TABLE 3: Epigenetics Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS
    • TABLE 4: Reagents (Product) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 5: Reagents (Product) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 6: Reagents (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 7: Kits (Product) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 8: Kits (Product) Historic Market Perspective by Region/Country in US$ Million: 2012 to
    • TABLE 9: Kits (Product) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 10: Instruments (Product) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 11: Instruments (Product) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to
    • TABLE 12: Instruments (Product) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 13: Enzymes (Product) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to
    • TABLE 14: Enzymes (Product) Market Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 15: Enzymes (Product) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 16: Services (Product) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 17: Services (Product) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 18: Services (Product) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 19: DNA Methylation (Technology) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to
    • TABLE 20: DNA Methylation (Technology) Market Worldwide Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 21: DNA Methylation (Technology) Market Percentage Share Distribution by Region/Country: 2012 VS 2020 VS
    • TABLE 22: Histone Methylation (Technology) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to
    • TABLE 23: Histone Methylation (Technology) Global Historic Demand in US$ Million by Region/Country: 2012 to
    • TABLE 24: Histone Methylation (Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 25: Histone Acetylation (Technology) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 26: Histone Acetylation (Technology) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 27: Histone Acetylation (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 28: Large Non - Coding RNA (Technology) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 29: Large Non - Coding RNA (Technology) Historic Market Perspective by Region/Country in US$ Million: 2012 to
    • TABLE 30: Large Non - Coding RNA (Technology) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 31: MicroRNA Modification (Technology) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 32: MicroRNA Modification (Technology) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to
    • TABLE 33: MicroRNA Modification (Technology) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 34: Chromatin Structures (Technology) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to
    • TABLE 35: Chromatin Structures (Technology) Market Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 36: Chromatin Structures (Technology) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 37: Oncology (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through
    • TABLE 38: Oncology (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to
    • TABLE 39: Oncology (Application) Global Market Share Distribution by Region/Country for 2012, 2020, and
    • TABLE 40: Non - Oncology (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2020
    • TABLE 41: Non - Oncology (Application) Historic Sales Analysis in US$ Million by Region/Country: 2012
    • TABLE 42: Non - Oncology (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Epigenetics Market Share (in %) by Company: 2019 &
    • Market Analytics
    • TABLE 43: United States Epigenetics Market Estimates and Projections in US$ Million by Product: 2020 to
    • TABLE 44: Epigenetics Market in the United States by Product: A Historic Review in US$ Million for 2012
    • TABLE 45: United States Epigenetics Market Share Breakdown by Product: 2012 VS 2020 VS
    • TABLE 46: Epigenetics Market in US$ Million in the United States by Technology: 2020
    • TABLE 47: United States Epigenetics Market Retrospective Analysis in US$ Million by Technology: 2012
    • TABLE 48: United States Epigenetics Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 49: United States Epigenetics Latent Demand Forecasts in US$ Million by Application: 2020 to
    • TABLE 50: Epigenetics Historic Demand Patterns in the United States by Application in US$ Million for 2012
    • TABLE 51: Epigenetics Market Share Breakdown in the United States by Application: 2012 VS 2020 VS
  • CANADA
    • TABLE 52: Canadian Epigenetics Market Estimates and Forecasts in US$ Million by Product: 2020 to
    • TABLE 53: Canadian Epigenetics Historic Market Review by Product in US$ Million: 2012
    • TABLE 54: Epigenetics Market in Canada: Percentage Share Breakdown of Sales by Product for 2012, 2020, and
    • TABLE 55: Epigenetics Market Analysis in Canada in US$ Million by Technology: 2020
    • TABLE 56: Epigenetics Market in Canada: Historic Review in US$ Million by Technology for the Period 2012
    • TABLE 57: Canadian Epigenetics Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 58: Canadian Epigenetics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to
    • TABLE 59: Epigenetics Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2012
    • TABLE 60: Canadian Epigenetics Market Share Analysis by Application: 2012 VS 2020 VS
  • JAPAN
    • TABLE 61: Japanese Market for Epigenetics: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2020
    • TABLE 62: Epigenetics Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2012
    • TABLE 63: Japanese Epigenetics Market Share Analysis by Product: 2012 VS 2020 VS
    • TABLE 64: Japanese Medium & Long-Term Outlook for Epigenetics Market in US$ Million by Technology: 2020
    • TABLE 65: Epigenetics Market in Japan in US$ Million by Technology: 2012
    • TABLE 66: Japanese Epigenetics Market Percentage Share Distribution by Technology: 2012 VS 2020 VS
    • TABLE 67: Japanese Demand Estimates and Forecasts for Epigenetics in US$ Million by Application: 2020 to
    • TABLE 68: Japanese Epigenetics Market in US$ Million by Application: 2012
    • TABLE 69: Epigenetics Market Share Shift in Japan by Application: 2012 VS 2020 VS
  • CHINA
    • TABLE 70: Chinese Epigenetics Market Growth Prospects in US$ Million by Product for the Period 2020
    • TABLE 71: Epigenetics Historic Market Analysis in China in US$ Million by Product: 2012
    • TABLE 72: Chinese Epigenetics Market by Product: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 73: Epigenetics Market Estimates and Forecasts in China in US$ Million by Technology: 2020
    • TABLE 74: Chinese Epigenetics Retrospective Market Scenario in US$ Million by Technology: 2012
    • TABLE 75: Epigenetics Market in China: Percentage Share Analysis by Technology for 2012, 2020, and
    • TABLE 76: Chinese Demand for Epigenetics in US$ Million by Application: 2020 to
    • TABLE 77: Epigenetics Market Review in China in US$ Million by Application: 2012
    • TABLE 78: Chinese Epigenetics Market Share Breakdown by Application: 2012 VS 2020 VS
  • EUROPE
    • Market Facts & Figures
    • European Epigenetics Market: Competitor Market Share Scenario (in %) for 2019 &
    • Market Analytics
    • TABLE 79: European Epigenetics Market Demand Scenario in US$ Million by Region/Country: 2020
    • TABLE 80: Epigenetics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012
    • TABLE 81: European Epigenetics Market Share Shift by Region/Country: 2012 VS 2020 VS
    • TABLE 82: European Epigenetics Market Estimates and Forecasts in US$ Million by Product: 2020
    • TABLE 83: Epigenetics Market in Europe in US$ Million by Product: A Historic Review for the Period 2012
    • TABLE 84: European Epigenetics Market Share Breakdown by Product: 2012 VS 2020 VS
    • TABLE 85: European Epigenetics Market Assessment in US$ Million by Technology: 2020
    • TABLE 86: European Epigenetics Historic Market Review in US$ Million by Technology: 2012
    • TABLE 87: Epigenetics Market in Europe: Percentage Breakdown of Sales by Technology for 2012, 2020, and
    • TABLE 88: European Epigenetics Addressable Market Opportunity in US$ Million by Application: 2020
    • TABLE 89: Epigenetics Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012
    • TABLE 90: European Epigenetics Market Share Analysis by Application: 2012 VS 2020 VS
  • FRANCE
    • TABLE 91: Epigenetics Market in France by Product: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 92: French Epigenetics Historic Market Scenario in US$ Million by Product: 2012
    • TABLE 93: French Epigenetics Market Share Analysis by Product: 2012 VS 2020 VS
    • TABLE 94: French Epigenetics Market Estimates and Projections in US$ Million by Technology: 2020
    • TABLE 95: French Epigenetics Historic Market Analysis in US$ Million by Technology: 2012
    • TABLE 96: French Epigenetics Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 97: Epigenetics Quantitative Demand Analysis in France in US$ Million by Application: 2020
    • TABLE 98: French Epigenetics Historic Market Review in US$ Million by Application: 2012
    • TABLE 99: French Epigenetics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and
  • GERMANY
    • TABLE 100: Epigenetics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2020
    • TABLE 101: German Epigenetics Historic Market Analysis in US$ Million by Product: 2012
    • TABLE 102: German Epigenetics Market Share Breakdown by Product: 2012 VS 2020 VS
    • TABLE 103: German Epigenetics Latent Demand Forecasts in US$ Million by Technology: 2020
    • TABLE 104: Epigenetics Market in Germany: A Historic Perspective by Technology in US$ Million for the Period 2012
    • TABLE 105: German Epigenetics Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 106: Epigenetics Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2020
    • TABLE 107: German Epigenetics Market in Retrospect in US$ Million by Application: 2012
    • TABLE 108: Epigenetics Market Share Distribution in Germany by Application: 2012 VS 2020 VS
  • ITALY
    • TABLE 109: Italian Epigenetics Market Growth Prospects in US$ Million by Product for the Period 2020
    • TABLE 110: Epigenetics Historic Market Analysis in Italy in US$ Million by Product: 2012
    • TABLE 111: Italian Epigenetics Market by Product: Percentage Breakdown of Sales for 2012, 2020, and
    • TABLE 112: Epigenetics Market Estimates and Forecasts in Italy in US$ Million by Technology: 2020
    • TABLE 113: Italian Epigenetics Retrospective Market Scenario in US$ Million by Technology: 2012
    • TABLE 114: Epigenetics Market in Italy: Percentage Share Analysis by Technology for 2012, 2020, and
    • TABLE 115: Italian Demand for Epigenetics in US$ Million by Application: 2020 to
    • TABLE 116: Epigenetics Market Review in Italy in US$ Million by Application: 2012
    • TABLE 117: Italian Epigenetics Market Share Breakdown by Application: 2012 VS 2020 VS
  • UNITED KINGDOM
    • TABLE 118: United Kingdom Market for Epigenetics: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2020
    • TABLE 119: Epigenetics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2012
    • TABLE 120: United Kingdom Epigenetics Market Share Analysis by Product: 2012 VS 2020 VS
    • TABLE 121: United Kingdom Medium & Long-Term Outlook for Epigenetics Market in US$ Million by Technology: 2020
    • TABLE 122: Epigenetics Market in the United Kingdom in US$ Million by Technology: 2012
    • TABLE 123: United Kingdom Epigenetics Market Percentage Share Distribution by Technology: 2012 VS 2020 VS
    • TABLE 124: United Kingdom Demand Estimates and Forecasts for Epigenetics in US$ Million by Application: 2020 to
    • TABLE 125: United Kingdom Epigenetics Market in US$ Million by Application: 2012
    • TABLE 126: Epigenetics Market Share Shift in the United Kingdom by Application: 2012 VS 2020 VS
  • REST OF EUROPE
    • TABLE 127: Rest of Europe Epigenetics Market Estimates and Forecasts in US$ Million by Product: 2020
    • TABLE 128: Epigenetics Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2012
    • TABLE 129: Rest of Europe Epigenetics Market Share Breakdown by Product: 2012 VS 2020 VS
    • TABLE 130: Rest of Europe Epigenetics Market Assessment in US$ Million by Technology: 2020
    • TABLE 131: Rest of Europe Epigenetics Historic Market Review in US$ Million by Technology: 2012
    • TABLE 132: Epigenetics Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2012, 2020, and
    • TABLE 133: Rest of Europe Epigenetics Addressable Market Opportunity in US$ Million by Application: 2020
    • TABLE 134: Epigenetics Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2012
    • TABLE 135: Rest of Europe Epigenetics Market Share Analysis by Application: 2012 VS 2020 VS
  • ASIA-PACIFIC
    • TABLE 136: Epigenetics Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 137: Asia-Pacific Epigenetics Historic Market Scenario in US$ Million by Product: 2012
    • TABLE 138: Asia-Pacific Epigenetics Market Share Analysis by Product: 2012 VS 2020 VS
    • TABLE 139: Asia-Pacific Epigenetics Market Estimates and Projections in US$ Million by Technology: 2020
    • TABLE 140: Asia-Pacific Epigenetics Historic Market Analysis in US$ Million by Technology: 2012
    • TABLE 141: Asia-Pacific Epigenetics Historic Market Analysis in US$ Million by Technology: 2012 VS 2020 VS
    • TABLE 142: Epigenetics Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2020
    • TABLE 143: Asia-Pacific Epigenetics Historic Market Review in US$ Million by Application: 2012
    • TABLE 144: Asia-Pacific Epigenetics Market Share Analysis: A 17-Year Perspective by Application for 2012, 2020, and
  • REST OF WORLD
    • TABLE 145: Rest of World Epigenetics Market Estimates and Forecasts in US$ Million by Product: 2020 to
    • TABLE 146: Rest of World Epigenetics Historic Market Review by Product in US$ Million: 2012
    • TABLE 147: Epigenetics Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2012, 2020, and
    • TABLE 148: Epigenetics Market Analysis in Rest of World in US$ Million by Technology: 2020
    • TABLE 149: Epigenetics Market in Rest of World: Historic Review in US$ Million by Technology for the Period 2012
    • TABLE 150: Rest of World Epigenetics Market Share Breakdown by Technology: 2012 VS 2020 VS
    • TABLE 151: Rest of World Epigenetics Market Quantitative Demand Analysis in US$ Million by Application: 2020 to
    • TABLE 152: Epigenetics Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2012
    • TABLE 153: Rest of World Epigenetics Market Share Analysis by Application: 2012 VS 2020 VS

IV. COMPETITION

  • Total Companies Profiled: 39